Immune Pharmaceuticals Corp Headquarters
The links below provide all the necessary information about Immune Pharmaceuticals Corp Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
Immune Pharmaceuticals - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/immune-pharmaceuticals
- Pharmaceutical Therapeutics Headquarters Regions Greater New York Area, East Coast, Northeastern US Founded Date 2010 Founders Daniel Teper, Jean Kadouche Operating Status Active Last Funding Type Post-IPO Equity Legal Name Immune Pharmaceuticals, Inc. Stock Symbol OTCQB:IMNP Company Type For Profit Phone Number 914-606-3500
Immune Pharmaceuticals, Inc. (IMNPQ) Company Profile & Facts
- https://finance.yahoo.com/quote/IMNPQ/profile/
- Immune Pharmaceuticals, Inc. 1 Bridge Plaza North Suite 270 Fort Lee, NJ 07024 United States 201-464-2677 https://www.immunepharma.com Sector(s) : Healthcare Industry : …
Immune Pharmaceuticals Corp - Company Profile and News
- https://www.bloomberg.com/profile/company/0621530D:US
- Company profile page for Immune Pharmaceuticals Corp including stock price, company news, press releases, executives, board members, and contact information
Immune Pharmaceuticals Inc - Company Profile and News
- https://www.bloomberg.com/profile/company/IMNP:US
- Company profile page for Immune Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information
Immune Pharmaceuticals Inc. | LinkedIn
- https://www.linkedin.com/company/immune-pharmaceuticals-ltd-
- Headquarters Fort Lee, New Jersey Type Public Company Founded 2010 Specialties Pharmaceuticals, Nanomabs, Monoclonal Antibodies, biotechnology, bullous pemphigoid , and biopharmaceuticals Locations...
Immune Pharmaceuticals Inc. - Company Profiles - BCIQ
- https://profiles.biocentury.com/companies/immune_pharmaceuticals_inc
- For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the …
Immune Pharmaceuticals Corp 3 Blackfan Cir Boston, MA
- https://www.mapquest.com/us/massachusetts/immune-pharmaceuticals-corp-370280032
- Immune Pharmaceuticals Corp. 3 Blackfan Cir. Boston MA 02115. (617) 713-8000 Website. Menu & Reservations. Make Reservations. Order Online Tickets. Tickets. See Availability.
IMNPQ | Immune Pharmaceuticals Inc. Profile | MarketWatch
- https://www.marketwatch.com/investing/stock/imnpq/company-profile
- Immune Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch.
Immune Pharmaceuticals, Inc. (IMNPQ) - Yahoo Finance
- https://finance.yahoo.com/quote/IMNPQ/
- Find the latest Immune Pharmaceuticals, Inc. (IMNPQ) stock quote, history, news and other vital information to help you with your stock trading and investing.
Immune Pharmaceuticals Corp | Better Business Bureau® Profile
- https://www.bbb.org/us/ma/boston/profile/pharmacy/immune-pharmaceuticals-corp-0021-247895
- This organization is not BBB accredited. Pharmacy in Boston, MA. See BBB rating, reviews, complaints, & more.
Acquisition of Immune Pharmaceuticals | Nasdaq
- https://www.nasdaq.com/press-release/acquisition-of-immune-pharmaceuticals-2021-03-29
- Immune Pharmaceuticals Inc has today received an unconditional offer by United General LTD. ( UK) to acquire control of Immune Pharmaceuticals Inc. 's public company. The intent would be to ...
Immune Pharmaceuticals - Crunchbase
- https://www.crunchbase.com/organization/immune-pharmaceuticals/people
- Immune Pharmaceuticals has 1 current employee profile, Co-Founder & Scientific Advisor Jean Kadouche. Immune Pharmaceuticals has 1 board member or advisor, Jean Kadouche . Contacts
Immune Pharmaceuticals CEO Updates Shareholders On …
- https://www.prnewswire.com/news-releases/immune-pharmaceuticals-ceo-updates-shareholders-on-company-progress-300190427.html
- NEW YORK, Dec. 9, 2015 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP) ("Immune" or the "Company") a clinical-stage company developing novel therapies for the treatment of immuno ...
Immune Pharmaceuticals Completes Merger with EpiCept …
- https://www.prnewswire.com/news-releases/immune-pharmaceuticals-completes-merger-with-epicept-corporation-221116351.html
- Through its merger with EpiCept Corporation in 2013, Immune expanded its oncology pipeline with additional clinical-stage product candidates. Immune is headquartered in the U.S., with its primary...
IMNPQ Stock | News | IMMUNE PHARMACEUTICALS Stock Price …
- https://markets.businessinsider.com/stocks/imnpq-stock
- Immune Pharmaceuticals Inc Registered Shs Stock , IMNPQ 0.00 EUR +0.00 +50.00% Official Close 5/9/2022 FSE
Did you find out everything you wanted about Immune Pharmaceuticals Corp Headquarters?
We are sure that the information collected for you about Immune Pharmaceuticals Corp Headquarters turned out to be more than enough.
